MEDICAMEN BIOTECH
Back to Balance Sheet
|
MEDICAMEN BIOTECH Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹83 Cr | ₹73 Cr | ₹53 Cr | ₹56 Cr | ₹49 Cr |
What is the latest Total Current Liabilities ratio of MEDICAMEN BIOTECH ?
Year | Total Current Liabilities |
---|---|
Mar2023 | ₹83 Cr |
Mar2022 | ₹73 Cr |
Mar2021 | ₹53 Cr |
Mar2020 | ₹56 Cr |
Mar2019 | ₹49 Cr |
How is Total Current Liabilities of MEDICAMEN BIOTECH Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹83 Cr | 13.60 | |
Mar2022 | ₹73 Cr | 36.45 | |
Mar2021 | ₹53 Cr | -5.68 | |
Mar2020 | ₹56 Cr | 16.36 | |
Mar2019 | ₹49 Cr | - |
Compare Total Current Liabilities of peers of MEDICAMEN BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MEDICAMEN BIOTECH | ₹684.3 Cr | 9.7% | 34.6% | -21.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
MEDICAMEN BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MEDICAMEN BIOTECH | 9.7% |
34.6% |
-21.5% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses